Obesity

ADRB3, LEPR, FTO and PPARG variants contribute to obesity-related metabolic syndrome in Brazilian adults: a polygenic risk score approach

Int J Obes (Lond)Published Case-control genetic association study

Authors' conclusion

Variants in ADRB3, LEPR, FTO and PPARG play an important role in adiposity related to MetS, contributing to metabolic disturbances and pro-inflammatory state that increase cardiovascular risk in adult subjects. The integration of these variants into a polygenic risk score highlights a cumulative genetic susceptibility, as reflected by higher scores in MetS and a clear gradient across the number of MetS components.

Study context

Population
Brazilian adults
Participants
420 adults
Comparison
Metabolic syndrome (MetS) vs without MetS
  • MetSn = 179
  • Without MetSn = 241reference
Outcome
Association of variants with risk of MetS
Methodological detailsselected from a Brazilian adult cohort, polygenic risk score
  • Selected from a Brazilian adult cohort
  • Polygenic risk score

Main finding

As reported in the abstract

Odds ratio (95% CI)P value
ADRB3 rs4994A>G
3.71(1.71–8.03)
P = 0.001
LEPR rs1137100A>G
2.52(1.33–4.79)
P = 0.005

Observational data: associations, not effects.

Further findings

Prediction of anthropometric, metabolic and inflammatory alterations related to MetS

ADRB3 rs4994A>G, LEPR rs1137100A>G, FTO rs17817449T>G and PPARG rs1801282C>G predicted MetS-related alterations
P < 0.05

Polygenic risk score (nPRS)

ROC discrimination of MetS (limited sensitivity), AUC
0.616, p < 0.001
Increasing nPRS associated with higher number of MetS components
P < 0.001
nPRS higher in subjects with MetS

Original publication

ADRB3, LEPR, FTO and PPARG variants contribute to obesity-related metabolic syndrome in Brazilian adults: a polygenic risk score approach. Int J Obes (Lond). Published 21 September 2026. doi:10.1038/s41366-026-02218-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.